ST
Stereotaxis, Inc.
STXS · AMEX
$1.32 +1.15% (+$0.02)
1M -9.59%
Market Cap $128.8M
P/E Ratio -
Div. Yield -
ROE 132.62%
Piotroski F-Score Weak
3/9Valuation
25 /100
Expensive P/S 4.28x
P/B 7.37x
P/E N/A
Growth
34 /100
Stable Rev. growth 4.78%
Book val. growth 16.30%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 55.57%
Net margin 74.24%
Op. margin 73.02%
Quality
7 /100
Poor ROIC 74.49%
ROE 132.62%
ROA 40.16%
Debt
89 /100
Low Debt/Equity 0.30x
Current ratio 1.42x
Int. coverage N/A
Stability
64 /100
Moderate Beta 1.42x
Rev. volatility 13.24%
EPS volatility 14.41%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o STXS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
David L. Fischel
Employees
131
Headquarters
St. Louis
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report